|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0016229,
umls-concept:C0016385,
umls-concept:C0030705,
umls-concept:C0181904,
umls-concept:C0231220,
umls-concept:C0235480,
umls-concept:C0596972,
umls-concept:C0728873,
umls-concept:C1280500,
umls-concept:C1521743,
umls-concept:C1623258,
umls-concept:C1704646
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2007-2-26
|
|
pubmed:abstractText |
A double-blind, randomized, parallel-group, placebo-controlled trial was conducted in patients with paroxysmal atrial fibrillation or flutter (PAF/PAFL) experiencing 2 or more episodes of symptomatic PAF/PAFL during a 28-day observation period to determine the dose-response effect and safety of flecainide.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1346-9843
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
71
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
294-300
|
|
pubmed:meshHeading |
pubmed-meshheading:17322624-Aged,
pubmed-meshheading:17322624-Atrial Fibrillation,
pubmed-meshheading:17322624-Continental Population Groups,
pubmed-meshheading:17322624-Dose-Response Relationship, Drug,
pubmed-meshheading:17322624-Double-Blind Method,
pubmed-meshheading:17322624-Electrocardiography,
pubmed-meshheading:17322624-Female,
pubmed-meshheading:17322624-Flecainide,
pubmed-meshheading:17322624-Humans,
pubmed-meshheading:17322624-Male,
pubmed-meshheading:17322624-Middle Aged,
pubmed-meshheading:17322624-Placebos,
pubmed-meshheading:17322624-Recurrence,
pubmed-meshheading:17322624-Telemedicine
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Dose-response effect of flecainide in patients with symptomatic paroxysmal atrial fibrillation and/or flutter monitored with trans-telephonic electrocardiography: a multicenter, placebo-controlled, double-blind trial.
|
|
pubmed:affiliation |
Department of Internal Medicine, Nippon Medical School, Tama-Nagayama Hospital, Japan. atarashi@nms.ac.jp
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
